Single-Center Experience with Hydrogen Breath Testing, Mainly for Suspected Small Intestinal Bacterial Overgrowth
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction: Hydrogen breath testing is used to investigate persistent unexplained gastrointestinal symptoms, particularly suspected small intestinal bacterial overgrowth (SIBO). The primary objective of this study was to describe hydrogen breath test utilization in our department and assess the impact of different diagnostic cutoffs on glucose breath test positivity, while secondary exploratory analyses evaluated associations with symptom burden, proton pump inhibitor use, and hydrogen curve dynamics. Methods: This retrospective single-center observational study included 205 patients referred for hydrogen breath testing (methane was not measured). Clinical data were collected using a standardized questionnaire. Glucose or lactulose was used for suspected SIBO, and lactose or fructose for carbohydrate malabsorption. Glucose tests were analyzed using rises of ≥10 ppm and ≥20 ppm above baseline. Results: Glucose was used in 195 patients. Among these tests, 94/195 (48.2%) were positive at the ≥10 ppm cutoff and 59/195 (30.3%) at the ≥20 ppm cutoff. The occurrence of symptoms during testing did not differ significantly between positive and negative tests at either threshold, though numerical trends were observed. However, cumulative symptom burden (total symptom scores) was significantly higher in patients with positive results at both ≥10 ppm [median 10 (IQR 0–30) vs. 1 (IQR 0–15.3), p = 0.008] and ≥20 ppm [median 14 (IQR 1–32) vs. 2 (IQR 0–18.5), p = 0.002]. A larger maximum hydrogen rise was weakly associated with greater symptom burden. PPI use within the previous 6 months showed a non-significant numerical trend toward higher test positivity. Most positive tests reached the diagnostic threshold within the first 60 min. Conclusions: In our center, glucose hydrogen breath testing was used mainly for suspected SIBO. Test positivity varied substantially according to the diagnostic cutoff. While binary symptom occurrence did not differ significantly between groups, the cumulative symptom burden was significantly higher in patients with positive results.
Source: Gastroenterology Insights
Authors: Liliana David(Conceptualization, Data curation, Investigation, Methodology, Writing – original draft), Abdulrahman Ismaiel(Investigation, Methodology, Supervision, Validation, Writing – review & editing), Castalia Maier(Formal analysis, Investigation, Methodology, Writing – original draft), Stefan-Lucian Popa(Investigation, Methodology, Supervision, Writing – review & editing), Dan L. Dumitrascu(Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing), Raphael Eftimie Spitz, Anda Pacurar, Teodora Surdea-Blaga(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Visualization, Writing – original draft)
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,930
OpenAlex ID: W7235224240
